Occupational Health and Safety Act
Loi sur la santé et la sécurité au travail
R.R.O. 1990, REGULATION 833
Amended to O. Reg. 607/05
CONTROL OF EXPOSURE TO BIOLOGICAL OR CHEMICAL AGENTS
Historical version for the period November 28, 2005 to December 30, 2005.
This Regulation is made in English only.
1. In this Regulation,
“exposure” means exposure by inhalation, ingestion or skin contact. R.R.O. 1990, Reg. 833, s. 1.
2. This Regulation does not apply at a project to an employer who primarily carries on the business of construction or to the workers of such an employer. R.R.O. 1990, Reg. 833, s. 2.
3. (1) Every employer shall take all measures reasonably necessary in the circumstances to protect workers from exposure to a hazardous biological or chemical agent because of the storage, handling, processing or use of such agent in the workplace. R.R.O. 1990, Reg. 833, s. 3 (1).
(2) The measures referred to in subsection (1) shall include the provision and use of engineering controls, work practices, hygiene facilities and practices and, subject to section 6, personal protective equipment. R.R.O. 1990, Reg. 833, s. 3 (2).
4. Without limiting the generality of section 3, but subject to section 9, every employer shall take the measures prescribed in section 3 to limit the exposure of workers to a biological or chemical agent listed in Part 4 or 11 of the Schedule, in accordance with all of the following rules:
Note: On December 31, 2007, section 4 is amended by striking out “but subject to section 9” in the portion before paragraph 1. See: O. Reg. 607/05, ss. 1, 8 (3).
1. If Part 4 or 11 sets out a time-weighted average exposure value (TWAEV) for the agent, exposure shall not exceed that value.
2. If Part 4 or 11 sets out a short-term exposure value (STEV) for the agent, exposure shall not exceed that value.
3. If Part 4 or 11 sets out a ceiling exposure value (CEV) for the agent, exposure shall not exceed that value.
4. If Part 4 or 11 sets out a TWAEV for the agent but neither a STEV nor a CEV, exposure shall not exceed the values calculated under Part 2B of the Schedule. O. Reg. 100/04, s. 1.
5. In determining the exposure of workers to a hazardous biological or chemical agent under section 3 or 4, no regard shall be had to the wearing and use of personal protective equipment. R.R.O. 1990, Reg. 833, s. 5.
6. Except in the circumstances set out in sections 7 and 9, an employer shall protect workers from exposure to a hazardous biological or chemical agent without requiring the workers to wear and use personal protective equipment. R.R.O. 1990, Reg. 833, s. 6.
Note: On December 31, 2007, section 6 is amended by striking out “sections 7 and 9” and substituting “section 7”. See: O. Reg. 607/05, ss. 2, 8 (3).
7. Where engineering controls required by this Regulation,
(a) are not in existence or are not obtainable;
(b) are not reasonable or not practical to adopt, install or provide because of the duration or frequency of the exposures or because of the nature of the process, operation or work;
(c) are rendered ineffective because of a temporary breakdown of such controls; or
(d) are ineffective to prevent, control or limit exposure because of an emergency,
the employer shall provide, and workers shall wear and use, personal protective equipment appropriate in the circumstances to protect the workers from exposure to a hazardous biological or chemical agent. R.R.O. 1990, Reg. 833, s. 7.
8. (1) Where a worker has been exposed to a hazardous biological or chemical agent and,
(a) the worker or the worker’s physician has reason to believe that the worker’s health has been affected by exposure to the agent and the worker or the worker’s physician has so notified the employer;
(b) the employer believes that the worker has been exposed to the agent, and the worker’s health is likely to be affected thereby and the employer has so notified the worker; or
(c) the Provincial Physician, Ministry of Labour so requires,
the worker, subject to subsection (2), shall at the expense of the employer undergo medical examinations and clinical tests to determine whether the worker has an occupational illness because of the exposure and whether the worker is fit, fit with limitations or unfit to continue working in such an exposure. R.R.O. 1990, Reg. 833, s. 8 (1); O. Reg. 513/92, s. 1.
(2) A notice under clause (1) (a) or (b) shall be in writing and a notice under clause (1) (b) shall notify the worker that the worker may dispute whether he or she must undergo medical examinations and clinical tests by giving notice of the dispute to an inspector. R.R.O. 1990, Reg. 833, s. 8 (2).
(3) Where a dispute arises between an employer and a worker under clause (1) (a) or (b) as to whether a worker must undergo medical examinations or clinical tests the employer or the worker may notify an inspector thereof who shall cause an investigation to be made and give a decision in writing to the employer and the worker. R.R.O. 1990, Reg. 833, s. 8 (3).
(4) The employer shall provide the physician who examines the worker or under whose supervision clinical tests are performed with a copy of the records, if any, of the exposure of the worker to the hazardous biological or chemical agent. R.R.O. 1990, Reg. 833, s. 8 (4).
9. (1) In this section,
“fibrous reinforcing agent” means an agent such as glass fibre or other fibrous substance used to strengthen a plastic material;
“plastic material” means a synthetic resinous polymeric substance that can be shaped or molded. R.R.O. 1990, Reg. 833, s. 9 (1).
(2) Every employer using styrene-based polyester resin in conjunction with a fibrous reinforcing agent to make or repair any goods, substance, article or thing, or part thereof, shall take all necessary measures and procedures by means of engineering controls, work practices and hygiene facilities and practices to ensure that the time-weighted average exposure of a worker to airborne styrene shall not exceed 100 parts styrene per million parts of air by volume, or 426 milligrams styrene per cubic metre of air. R.R.O. 1990, Reg. 833, s. 9 (2).
Note: On March 1, 2006, subsection (2) is revoked and the following substituted:
(2) Every employer using styrene-based polyester resin in conjunction with a fibrous reinforcing agent to make or repair any goods, substance, article or thing, or part thereof, shall ensure that the exposure of workers to airborne styrene does not exceed the time-weighted average exposure value and short-term exposure value set out in Part 4 of the Schedule. O. Reg. 607/05, s. 3 (1).
See: O. Reg. 607/05, ss. 3 (1), 8 (2).
(3) Where subsection (2) applies, the employer shall provide a worker with respiratory equipment which shall be used by the worker if the time-weighted average exposure of a worker to airborne styrene is greater than 50 but less than 100 parts styrene per million parts of air by volume. R.R.O. 1990, Reg. 833, s. 9 (3).
Note: On March 1, 2006, subsection (3) is revoked and the following substituted:
(3) An employer described in subsection (2) may provide respiratory equipment to a worker to ensure the worker’s exposure to airborne styrene does not exceed the time-weighted average exposure value and short-term exposure value set out in Part 4 of the Schedule if,
(a) the time-weighted average exposure of the worker to airborne styrene is greater than 50 but less than or equal to 100 parts styrene per million parts of air by volume; or
(b) the short-term exposure of the worker to airborne styrene, measured over 15 minutes, is greater than 100 but less than or equal to 200 parts styrene per million parts of air by volume. O. Reg. 607/05, s. 3 (1).
See: O. Reg. 607/05, ss. 3 (1), 8 (2).
(4) Despite subsection (2), an employer shall ensure that the exposure of a worker to styrene shall not exceed a short-term exposure concentration, measured over fifteen minutes, of 200 parts styrene per million parts of air by volume or 852 milligrams styrene per cubic metre of air. R.R.O. 1990, Reg. 833, s. 9 (4).
Note: On March 1, 2006, subsection (4) is revoked and the following substituted:
(4) Every worker who is provided with respiratory equipment by an employer under subsection (3) shall use the respiratory equipment. O. Reg. 607/05, s. 3 (1).
See: O. Reg. 607/05, ss. 3 (1), 8 (2).
Note: On December 31, 2007, section 9 is revoked. See: O. Reg. 607/05, ss. 3 (2), 8 (3).
SCHEDULE
EXPOSURE VALUES FOR BIOLOGICAL AND CHEMICAL AGENTS IN WORKPLACES
Agents have been assigned to tables given in Parts 4, 9, 10 and 11 of the Schedule.
Also, many of the agents’ names in the Schedule are based on the naming rules of the International Union of Pure and Applied Chemistry (IUPAC).
TABLE OF CONTENTS
Part | |
Biological and Chemical Agents |
|
Part 1 Revoked: O. Reg. 388/00, s. 3. |
|
Calculation of Exposure Values |
2A |
Excursion Limits Where Neither a Short-Term Exposure Value (STEV) nor a Ceiling Exposure Value (CEV) is Indicated |
2B |
Explanatory Notes on Chemical Names, CAS Reg. Nos., and Other Notations |
3 |
Time-Weighted Average Exposure Values (TWAEV), Short-Term Exposure Values (STEV) and Ceiling Exposure Values (CEV) |
4 |
Part 5 Revoked: O. Reg. 388/00, s. 7. |
|
Part 6 Revoked: O. Reg. 388/00, s. 7. |
|
Part 7 Revoked: O. Reg. 388/00, s. 7. |
|
Part 8 Revoked: O. Reg. 388/00, s. 7. |
|
Exposure Values for Simple Asphyxiants |
9 |
Known Toxic Agents for Which Exposure Values Have Not Been Established, and to Which Any Exposure Should be Avoided |
10 |
Exposure Values for Acrylonitrile, Benzene and Mercury |
11 |
PART 1 Revoked: O. Reg. 388/00, s. 3.
PART 2A
CALCULATION OF EXPOSURE VALUES
1. The time-weighted average exposure value (TWAEV) is the average of the airborne concentrations of a biological or chemical agent determined from air samples of the airborne concentrations to which a worker is exposed in a work day or a work week.
2. The short-term exposure value (STEV) is the maximum airborne concentration of a biological or chemical agent to which a worker is exposed in any fifteen-minute period determined from a single sample or a time-weighted average of sequential samples taken during such period.
3. The ceiling exposure value (CEV) is the maximum airborne concentration of a biological or chemical agent to which a worker is exposed at any time.
4. The airborne concentrations of the agent are expressed as parts of the agent per million parts of air by volume (ppm) or as milligrams of the agent per cubic metre of air (mg/m3).
5. Air sampling of the airborne concentrations of an agent is not required for the full period of a work day or a work week where the air sampling is representative of airborne concentrations of an agent likely to be present during the period.
6. The method of air sampling, the number and volume of the air samples and the method of analyses of the air samples shall be determined according to the nature of the operations or processes and the characteristics of the agent in accordance with recognized industrial hygiene practice.
7. In determining exposure to airborne concentrations of a biological or chemical agent, no regard shall be had or taken to the wearing or use by a worker of respiratory equipment.
8. The daily and weekly time-weighted exposure values shall be calculated as follows:
(a) C1T1 + C2T2 + ... + CnTn = cumulative daily or weekly exposure, where Ci is the concentration found in an air sample and Ti is the total time in hours to which the worker is taken to be exposed to concentration Ci in a work day or a work week for i taking on the values of 1, 2, ..., n.
(b) The time-weighted average exposure shall be calculated by dividing the cumulative daily exposure by 8 and the weekly exposure by 40 respectively.
9. For mixtures of airborne chemical agents which exert an additive health effect and when analytical results of individual airborne agents are available, the following formula shall be used:
where C1, C2, ... , Cn are the concentrations found in the air sample;
and L1, L2, ... , Ln are the respective exposure values for the agents set out in the Schedule.
The sum of these ratios, E, shall not exceed 1.
When calculating E for time-weighted average exposures, C shall be taken to be the time-weighted average exposure value calculated for each agent.
10. Paragraph 9 does not apply where the agents have widely different health effects. In such circumstances, independent exposure values for each agent shall be used and calculated in accordance with paragraph 8.
R.R.O. 1990, Reg. 833, Sched., Part 2A.
PART 2B
EXCURSION LIMITS WHERE NEITHER A SHORT-TERM EXPOSURE VALUE (STEV) NOR A CEILING EXPOSURE VALUE (CEV) IS INDICATED
1. Where a TWAEV but neither a STEV nor a CEV is set out for a biological or chemical agent listed in Part 4 or 11 of this Schedule, a worker shall not be exposed to a concentration of the biological or chemical agent that exceeds,
(a) three times the TWAEV set out in this Schedule with respect to that agent for any period of 30 minutes; and
(b) five times the TWAEV set out in this Schedule with respect to that agent for any period of time.
O. Reg. 100/04, s. 3.
PART 3
EXPLANATORY NOTES ON CHEMICAL NAMES, CAS REG. NOS., AND OTHER NOTATIONS
Parts 4, 9, 10 and 11 of this Schedule deal with biological and chemical agents and contain names of the agents, Chemical Abstracts Service Registry Numbers, and some notations.
Chemical Names
The chemical names used in this Schedule conform with nomenclature rules of the International Union of Pure and Applied Chemistry or with common usage.
Numerals and prefixes (e.g.: o-, p-, n-, O-, N-, sec-, tert-) are disregarded when listing the main entries in alphabetical order, but are used to assign the order when main entry names are identical. For example, “N-methylaniline” is listed under “m”, and “sec-butyl acetate” precedes “tert-butyl acetate”.
Chemical Abstracts Service Registry Number
The Chemical Abstracts Service Registry Number (CAS Reg. No.) is a unique numerical identifier assigned to a chemical substance in the CAS registry system by the Chemical Abstracts Service (P.O. Box 3012, Columbus, Ohio, 43210). The CAS Reg. No. itself has no chemical or structural significance; it is merely a computer-verifiable number assigned in sequential order to each agent as it is entered in the CAS registry system. Some of the CAS Reg. Nos. listed in this guide were assigned by the CAS under contract for the United States Environmental Protection Agency (U.S. EPA). CAS Reg. Nos. have been used as chemical or biological identifiers in inventories and computer literature-retrieval systems.
The CAS Reg. No. has the format (xxxxxx-xx-x) and consists of up to 9 digits, separated by hyphens into 3 groups: (a) the first group has up to 6 digits; (b) the second always contains 2 digits; and (c) the third contains 1 digit.
Notations
The notation “inhalable” following the name of an agent in this Schedule means that size fraction of the airborne particulate deposited anywhere in the respiratory tract and collected during air sampling with a particle size-selective device that,
(a) meets the American Conference of Governmental Industrial Hygienists (ACGIH) particle size-selective criteria; and
(b) has the cut point of 100 microns at 50 per cent collective efficiency.
The notation “respirable” following the name of an agent in this Schedule means that size fraction of the airborne particulate deposited in the gas-exchange region of the respiratory tract and collected during air sampling with a particle size-selective device that,
(a) meets the American Conference of Governmental Industrial Hygienists (ACGIH) particle size-selective criteria; and
(b) has the cut point of 4 microns at 50 per cent collective efficiency.
The notation “skin” following the name of an agent in this Schedule indicates that direct or airborne contact with the agents may result in significant absorption of the agent through the skin, mucous membranes or eyes. Vehicles, such as certain solvents, may enhance the rate of skin absorption. Inclusion of this notation is intended to suggest that preventative action should be taken against absorption of the agent through the skin, mucous membranes or eyes.
The notation “thoracic” following the name of an agent in this Schedule means that size fraction of the airborne particulate deposited anywhere in the lung airways and the gas-exchange region of the respiratory tract and collected during air sampling with a particle size-selective device that,
(a) meets the American Conference of Governmental Industrial Hygienists (ACGIH) particle size-selective criteria; and
(b) has the cut point of 10 microns at 50 per cent collective efficiency.
(As...) — In the lists of biological and chemical agents, the notation “(as...)”, e.g.: “nickel carbonyl (as nickel)”, is used to indicate that the agent is to be analyzed for the substance indicated in parentheses, nickel in this example, rather than nickel carbonyl.
O. Reg. 100/04, s. 4; O. Reg. 607/05, s. 4.
PART 4
TIME-WEIGHTED AVERAGE EXPOSURE VALUES (TWAEV), SHORT-TERM EXPOSURE VALUES (STEV) AND CEILING EXPOSURE VALUES (CEV)
AGENT |
TWAEV |
STEV |
CEV | |||||||
(CAS Reg. no) |
ppm |
mg/m3 |
ppm |
mg/m3 |
ppm |
mg/m3 | ||||
Acetaldehyde |
||||||||||
(75-07-0) |
25 |
|||||||||
Acetic acid |
||||||||||
(64-19-7) |
10 |
25 |
15 |
37 |
||||||
Acetic anhydride |
||||||||||
(108-24-7) |
5 |
21 | ||||||||
Acetone |
||||||||||
(67-64-1) |
500 |
750 |
||||||||
Acetone cyanohydrin |
||||||||||
(75-86-5), as CN — Skin |
4.7 |
|||||||||
Acetonitrile |
||||||||||
(75-05-8) — Skin |
20 |
|||||||||
Acetophenone |
||||||||||
(98-86-2) |
10 |
|||||||||
2-(Acetyloxy) benzoic acid |
||||||||||
(50-78-2) |
5 |
|||||||||
Acrolein |
||||||||||
(107-02-8) |
0.1 |
|||||||||
Acrylamide, inhalable, vapour and aerosol |
||||||||||
(79-06-1) — Skin |
0.03 |
|||||||||
Acrylic acid |
||||||||||
(79-10-7) |
2 |
|||||||||
Adipic acid |
||||||||||
(124-04-9) |
5 |
|||||||||
Adiponitrile |
||||||||||
(111-69-3) — Skin |
2 |
|||||||||
Aldrin |
||||||||||
(309-00-2) — Skin |
0.25 |
|||||||||
Allyl alcohol |
||||||||||
(107-18-6) — Skin |
0.5 |
|||||||||
Allyl chloride |
||||||||||
(107-05-1) |
1 |
3 |
2 |
6 |
||||||
Allyl propyl disulfide |
||||||||||
(2179-59-1) |
0.5 |
|||||||||
alpha-Alumina (total dust) |
||||||||||
(1344-28-1) |
10 |
|||||||||
Aluminum-powder |
||||||||||
(7429-90-5) |
5 |
|||||||||
Aluminum, alkyl derivatives of |
||||||||||
(7429-90-5) |
2 |
|||||||||
Aluminum, metal and oxide dust |
||||||||||
(7429-90-5) |
10 |
|||||||||
Aluminum, water-soluble compounds of |
||||||||||
(7429-90-5) |
2 |
|||||||||
2-Aminoethanol |
||||||||||
(141-43-5) |
3 |
7.5 |
6 |
15 |
||||||
2-Aminopyridine |
||||||||||
(504-29-0) |
0.5 |
2 |
||||||||
3-Amino-1 H-1,2,4-triazole |
||||||||||
(61-82-5) |
0.2 |
|||||||||
4-Amino-3,5,6-trichloro-2-pyridinecarboxylic acid |
||||||||||
(1918-02-1) |
10 |
20 |
||||||||
Ammonia |
||||||||||
(7664-41-7) |
25 |
17 |
35 |
24 |
||||||
Ammonium chloride fume |
||||||||||
(12125-02-9) |
10 |
20 |
||||||||
Ammonium perfluoro-octanoate |
||||||||||
(3825-26-1) |
0.01 |
|||||||||
Ammonium sulfamate |
||||||||||
(7773-06-0) |
10 |
|||||||||
tert-Amyl methyl ether (TAME) |
||||||||||
(994-05-8) |
20 |
|||||||||
Aniline and homologues |
||||||||||
(62-53-3) — Skin |
2 |
8 |
||||||||
Anisidine (sum of o-, and p-isomers) |
||||||||||
(29191-52-4) — Skin |
0.1 |
0.5 |
||||||||
Antimony and its compounds, including antimony trioxide handling and use, but excluding stibine (as antimony) |
||||||||||
(7440-36-0) |
0.5 |
|||||||||
Antimony hydride |
||||||||||
(7803-52-3) |
0.1 |
0.5 |
||||||||
Arsine |
||||||||||
(7784-42-1) |
0.05 |
0.16 |
||||||||
Asphalt (Bitumen) fume, as benzene-soluble aerosol, inhalable |
||||||||||
(8052-42-4) |
0.5 |
|||||||||
Atrazine |
||||||||||
(1912-24-9) |
5 |
|||||||||
Azinphos-methyl, inhalable, vapour and aerosol |
||||||||||
(86-50-0) — Skin |
0.2 |
|||||||||
Barium carbonate, chloride, nitrate, or oxide (as barium) |
||||||||||
(7440-39-3) |
0.5 |
|||||||||
Barium sulfate (total dust) |
||||||||||
(7727-43-7) |
10 |
|||||||||
Benomyl |
||||||||||
(17804-35-2) |
0.8 |
9 |
||||||||
Benzaldehyde |
||||||||||
(100-52-7) |
4 |
17 |
||||||||
1,2-Benzenedicarboxylic acid bis(2-ethylhexyl) ester |
||||||||||
(117-81-7) |
3 |
5 |
||||||||
Benzotrichloride |
||||||||||
(98-07-7) — Skin |
0.1 |
|||||||||
Benzoyl chloride |
||||||||||
(98-88-4) |
0.5 |
|||||||||
Benzoyl peroxide |
||||||||||
(94-36-0) |
5 |
|||||||||
Benzyl acetate |
||||||||||
(140-11-4) |
10 |
|||||||||
Benzyl chloride |
||||||||||
(100-44-7) |
1 |
5 |
||||||||
Beryllium and its compounds (as beryllium) |
||||||||||
(7440-41-7) |
0.002 |
0.01 |
||||||||
Biphenyl |
||||||||||
(92-52-4) |
0.2 |
1.3 |
||||||||
Bis(eta-cyclopentadienyl)iron |
||||||||||
(102-54-5) |
10 |
|||||||||
Bis(2-(dimethylaminoethyl)) ether (DMAEE) |
||||||||||
(3033-62-3) — Skin |
0.05 |
0.15 |
||||||||
2,6-Bis(1,1-dimethylethyl)-4-methylphenol, also known as Butylated hydroxytoluene (BHT), inhalable, vapour and aerosol |
||||||||||
(128-37-0) |
2 |
|||||||||
Bis(dimethylthiocarbonyl) disulfide |
||||||||||
(137-26-8) |
1 |
|||||||||
Bismuth telluride |
||||||||||
(1304-82-1) |
10 |
|||||||||
Bismuth telluride, selenium-doped |
||||||||||
(1304-82-1) |
5 |
|||||||||
Borate compounds, Inorganic, inhalable |
||||||||||
- Anhydrous (1330-43-4) |
2 |
6 |
||||||||
- Decahydrate (1303-96-4) |
2 |
6 |
||||||||
- Orthoboric acid (10043-35-3) |
2 |
6 |
||||||||
- Pentahydrate (12179-04-3) |
2 |
6 |
||||||||
Boron oxide |
||||||||||
(1303-86-2) |
10 |
|||||||||
Boron tribromide |
||||||||||
(10294-33-4) |
1 |
10 | ||||||||
Boron trifluoride |
||||||||||
(7637-07-2) |
1 |
2.8 | ||||||||
Bromacil |
||||||||||
(314-40-9) |
10 |
|||||||||
Bromine |
||||||||||
(7726-95-6) |
0.1 |
0.2 |
||||||||
Bromine pentafluoride |
||||||||||
(7789-30-2) |
0.1 |
0.7 |
||||||||
Bromochloromethane |
||||||||||
(74-97-5) |
200 |
1,060 |
250 |
1,320 |
||||||
Bromoform |
||||||||||
(75-25-2) — Skin |
0.5 |
5 |
||||||||
1-Bromopropane |
||||||||||
(106-94-5) |
10 |
|||||||||
Bromotrifluoromethane |
||||||||||
(75-63-8) |
1,000 |
6,085 |
||||||||
1,3-Butadiene |
||||||||||
(106-99-0) |
5 |
|||||||||
Note: On December 31, 2005, Part 4 of the Schedule is amended by striking out, | ||||||||||
1,3-Butadiene |
||||||||||
(106-99-0) |
5 |
|||||||||
and substituting the following: | ||||||||||
1, 3-Butadiene |
||||||||||
(106-99-0) |
2 |
|||||||||
See: O. Reg. 16/05, ss. 1 (2), 2 (2). | ||||||||||
Butane, all isomers |
||||||||||
(106-97-8) |
800 |
1,900 |
||||||||
1-Butanethiol |
||||||||||
(109-79-5) |
0.5 |
1.8 |
||||||||
2-Butanone |
||||||||||
(78-93-3) |
200 |
590 |
300 |
885 |
||||||
2-Butoxyethanol |
||||||||||
(111-76-2) — Skin |
20 |
|||||||||
2-Butoxyethyl acetate (EGBEA) |
||||||||||
(112-07-2) |
20 |
|||||||||
n-Butyl acetate |
||||||||||
(123-86-4) |
150 |
710 |
200 |
950 |
||||||
sec-Butyl acetate |
||||||||||
(105-46-4) |
200 |
950 |
||||||||
tert-Butyl acetate |
||||||||||
(540-88-5) |
200 |
950 |
||||||||
n-Butyl acrylate |
||||||||||
(141-32-2) |
2 |
|||||||||
n-Butyl glycidyl ether (BGE), also known as (Butoxymethyl) oxirane |
||||||||||
(2426-08-6) — Skin |
3 |
|||||||||
n-Butanol, also known as n-Butyl alcohol |
||||||||||
(71-36-3) |
20 |
|||||||||
sec-Butyl alcohol |
||||||||||
(78-92-2) |
100 |
303 |
150 |
454 |
||||||
tert-Butyl alcohol |
||||||||||
(75-65-0) |
100 |
303 |
150 |
454 |
||||||
n-Butyl lactate |
||||||||||
(138-22-7) |
5 |
30 |
||||||||
n-Butylamine |
||||||||||
(109-73-9) — Skin |
5 |
15 | ||||||||
o-sec-Butylphenol |
||||||||||
(89-72-5) — Skin |
5 |
31 |
||||||||
p-tert-Butyltoluene |
||||||||||
(98-51-1) |
1 |
|||||||||
tert-Butyl chromate, (as chromate) |
||||||||||
(1189-85-1) — Skin |
0.1 | |||||||||
Cadmium, elemental |
||||||||||
(7440-43-9), and compounds, as Cd |
0.01 |
|||||||||
Cadmium, elemental |
||||||||||
(7440-43-9), and compounds, as Cd, respirable |
0.002 |
|||||||||
Calcium carbonate |
||||||||||
(471-34-1) |
10 (D) |
|||||||||
Calcium chloride |
||||||||||
(10043-52-4) |
5 |
|||||||||
Calcium chromate |
||||||||||
(13765-19-0), as Cr |
0.001 |
|||||||||
Calcium cyanamide |
||||||||||
(156-62-7) |
0.5 |
|||||||||
Calcium hydroxide |
||||||||||
(1305-62-0) |
5 |
|||||||||
Calcium oxide |
||||||||||
(1305-78-8) |
2 |
|||||||||
Calcium silicate (total dust) |
||||||||||
(1344-95-2) |
10 |
|||||||||
Calcium sulfate, including plaster of Paris (total dust) |
||||||||||
(10101-41-4) |
10 |
|||||||||
Camphor |
||||||||||
(76-22-2) |
2 |
12 |
3 |
19 |
||||||
Caprolactam, inhalable, vapour and aerosol |
||||||||||
(105-60-2) |
5 |
|||||||||
Captafol |
||||||||||
(2425-06-1) — Skin |
0.1 |
|||||||||
Captan, inhalable |
||||||||||
(133-06-2) |
5 |
|||||||||
Carbofuran, inhalable, vapour and aerosol |
||||||||||
(1563-66-2) |
0.1 |
|||||||||
Carbon black |
||||||||||
(1333-86-4) |
3.5 |
|||||||||
Carbon dioxide |
||||||||||
(124-38-9) |
5,000 |
9,000 |
30,000 |
54,000 |
||||||
Carbon disulfide |
||||||||||
(75-15-0) — Skin |
10 |
31 |
||||||||
Carbon monoxide |
||||||||||
(630-08-0) |
35 |
40 |
400 |
460 |
||||||
Note: On December 31, 2005, Part 4 of the Schedule is amended by striking out, | ||||||||||
Carbon monoxide |
||||||||||
(630-08-0) |
35 |
40 |
400 |
460 |
||||||
and substituting the following: | ||||||||||
Carbon monoxide |
||||||||||
(630-08-0) |
25 |
29 |
100 |
115 |
||||||
See: O. Reg. 16/05, ss. 1 (2), 2 (2). | ||||||||||
Carbon tetrabromide |
||||||||||
(558-13-4) |
0.1 |
1.4 |
0.3 |
4.1 |
||||||
Carbon tetrachloride |
||||||||||
(56-23-5) — Skin |
2 |
13 |
3 |
19 |
||||||
Carbonyl chloride |
||||||||||
(75-44-5) |
0.1 |
0.4 |
||||||||
Carbonyl fluoride |
||||||||||
(353-50-4) |
2 |
5.4 |
5 |
13 |
||||||
Cellulose (paper fibre, total dust) |
||||||||||
(9004-34-6) |
10 |
|||||||||
Cesium hydroxide |
||||||||||
(21351-79-1) |
2 |
|||||||||
Charcoal, except activated |
||||||||||
(16291-96-6) |
10 |
|||||||||
Chloroacetaldehyde |
||||||||||
(107-20-0) |
1 |
3 | ||||||||
Chlordane |
||||||||||
(57-74-9) — Skin |
0.5 |
2 |
||||||||
Chlorinated diphenyl oxides |
||||||||||
(55720-99-5) |
0.5 |
2 |
||||||||
Chlorine |
||||||||||
(7782-50-5) |
0.5 |
1 |
||||||||
Chlorine dioxide |
||||||||||
(10049-04-4) |
0.1 |
0.3 |
0.3 |
0.9 |
||||||
Chlorine trifluoride |
||||||||||
(7790-91-2) |
0.1 |
0.4 | ||||||||
Chloroacetone |
||||||||||
(78-95-5) |
1 |
|||||||||
Chloroacetyl chloride |
||||||||||
(79-04-9) |
0.05 |
0.15 |
||||||||
Chlorobenzene |
||||||||||
(108-90-7) |
10 |
|||||||||
o-Chlorobenzaldehyde |
||||||||||
(89-98-5) |
4 |
23 |
||||||||
o-Chlorobenzylidene malononitrile |
||||||||||
(2698-41-1) — Skin |
0.05 |
0.4 | ||||||||
2-Chloro-1,3-butadiene |
||||||||||
(126-99-8) — Skin |
10 |
36 |
||||||||
Chlorodifluoromethane |
||||||||||
(75-45-6) |
1,000 |
3,535 |
1,250 |
4,415 |
||||||
1-Chloro-2,3-epoxypropane |
||||||||||
(106-89-8) — Skin |
0.5 |
|||||||||
2-Chloroethanol |
||||||||||
(107-07-3) — Skin |
1 |
3.3 | ||||||||
p-Chloronitrobenzene |
||||||||||
(100-00-5) |
0.1 |
0.6 |
||||||||
1-Chloro-1-nitropropane |
||||||||||
(600-25-9) |
2 |
10 |
||||||||
Chloropentafluoroethane |
||||||||||
(76-15-3) |
1,000 |
6,315 |
||||||||
2-Chloro-1-phenylethanone |
||||||||||
(532-27-4) |
0.05 |
0.32 |
||||||||
1-Chloro-2-propanol |
||||||||||
(127-00-4) — Skin |
1 |
|||||||||
2-Chloro-1-propanol |
||||||||||
(78-89-7) — Skin |
1 |
|||||||||
2-Chloropropionic acid |
||||||||||
(598-78-7) — Skin |
0.1 |
|||||||||
o-Chlorostyrene |
||||||||||
(2039-87-4) |
50 |
283 |
75 |
425 |
||||||
o-Chlorotoluene |
||||||||||
(95-49-8) |
50 |
260 |
75 |
388 |
||||||
2-Chloro-6-(trichloro-methyl)pyridine |
||||||||||
(1929-82-4) |
10 |
20 |
||||||||
Chlorpyrifos, inhalable, vapour and aerosol |
||||||||||
(2921-88-2) — Skin |
0.1 |
|||||||||
Chromates, dichromates and other hexavalent chromium compounds (as chromium) |
||||||||||
(7440-47-3) |
0.05 |
|||||||||
Chromium |
||||||||||
(7440-47-3), insoluble Cr VI compounds, as Cr |
0.01 |
|||||||||
Chromium metal, and divalent and trivalent chromium compounds (as chromium) |
||||||||||
(7440-47-3) |
0.5 |
|||||||||
Chromyl chloride |
||||||||||
(14977-61-8) |
0.025 |
0.16 |
||||||||
Clopidol |
||||||||||
(2971-90-6) |
10 |
20 |
||||||||
Coal dust, Anthracite (respirable) |
0.4 |
|||||||||
Coal dust, Bituminous (respirable) |
0.9 |
|||||||||
Coal tar pitch volatiles (as total benzene-soluble compounds) |
||||||||||
(65996-93-2) |
0.2 |
|||||||||
Cobalt carbonyl and hydrocarbonyl (as cobalt) |
||||||||||
(7440-48-4) |
0.1 |
|||||||||
Cobalt metal, dust and fume (as cobalt) |
||||||||||
(7440-48-4) |
0.02 |
|||||||||
N-Coco morpholine |
||||||||||
(1541-81-7) — Skin |
5 |
52 |
||||||||
Copper fume (as copper) |
||||||||||
(7440-50-8) |
0.2 |
|||||||||
Copper dust and mists (as copper) |
||||||||||
(7440-50-8) |
1 |
|||||||||
Cotton dust, fabric knitting |
0.5 |
|||||||||
Cotton dust, raw |
0.2(F) |
|||||||||
Cotton dust, slashing and weaving |
0.75(F) |
|||||||||
Cotton dust, waste |
0.5(F) |
|||||||||
‘Coumin 100’ Polymer Flakes (total dust) |
||||||||||
(63393-89-5) |
5 |
|||||||||
Cresol (sum of o-, m-, and p-isomers) |
||||||||||
(1319-77-3) — Skin |
5 |
22 |
||||||||
Crotonaldehyde |
||||||||||
(4170-30-3) |
0.3 |
|||||||||
Crufomate |
||||||||||
(299-86-5) |
5 |
20 |
||||||||
Cumene |
||||||||||
(98-82-8) — Skin |
50 |
245 |
||||||||
Cyanamide |
||||||||||
(420-04-2) |
2 |
|||||||||
Cyanogen |
||||||||||
(460-19-5) |
10 |
21 |
||||||||
Cyanogen chloride |
||||||||||
(506-77-4) |
0.3 |
0.75 | ||||||||
Cyclohexane |
||||||||||
(110-82-7) |
100 |
|||||||||
Cyclohexanol |
||||||||||
(108-93-0) — Skin |
50 |
200 |
||||||||
Cyclohexanone |
||||||||||
(108-94-1) — Skin |
20 |
50 |
||||||||
Cyclohexene |
||||||||||
(110-83-8) |
300 |
1,010 |
||||||||
Cyclohexylamine |
||||||||||
(108-91-8) |
10 |
40 |
||||||||
Cyclopentadiene |
||||||||||
(542-92-7) |
75 |
200 |
||||||||
Cyclopentane |
||||||||||
(287-92-3) |
600 |
1,720 |
||||||||
Cyhexatin |
||||||||||
(13121-70-5) |
5 |
|||||||||
Cymene (sum of o-,m- and p-isomers) |
||||||||||
(25155-15-1) — Skin |
50 |
274 |
||||||||
Decaborane |
||||||||||
(17702-41-9) — Skin |
0.05 |
0.25 |
0.15 |
0.75 |
||||||
Demeton, inhalable, vapour and aerosol |
||||||||||
(8065-48-3) — Skin |
0.05 |
|||||||||
Demeton-S-methyl, inhalable, vapour and aerosol |
||||||||||
(919-86-8) — Skin |
0.05 |
|||||||||
1,2-Diaminoethane |
||||||||||
(107-15-3) |
10 |
25 |
||||||||
Diatomaceous earth, (uncalcined) inhalable |
||||||||||
(61790-53-2) |
10(D) |
|||||||||
Diatomaceous earth (uncalcined) respirable |
||||||||||
(61790-53-2) |
3(D) |
|||||||||
Diazinon, inhalable, vapour and aerosol, also known as Phosphorothionic acid 0,0-diethyl 0-(6-methyl)-2-(1-methylethyl)-4-pyrimidinyl) ester |
||||||||||
(333-41-5) — Skin |
0.01 |
|||||||||
Diazomethane |
||||||||||
(334-88-3) |
0.2 |
0.34 |
||||||||
Diborane |
||||||||||
(19287-45-7) |
0.1 |
0.11 |
||||||||
Dibromodifluoromethane |
||||||||||
(75-61-6) |
100 |
860 |
||||||||
2-N-(Dibutylamino) ethanol |
||||||||||
(102-81-8) — Skin |
0.5 |
|||||||||
Dibutyl phenyl phosphate |
||||||||||
(2528-36-1) — Skin |
0.3 |
|||||||||
Dibutyl phosphate |
||||||||||
(107-66-4) |
1 |
8.6 |
2 |
17 |
||||||
Dibutyl phthalate |
||||||||||
(84-74-2) |
5 |
|||||||||
Dichloroacetic acid |
||||||||||
(79-43-6) — Skin |
0.5 |
|||||||||
o-Dichlorobenzene |
||||||||||
(95-50-1) |
25 |
50 |
||||||||
p-Dichlorobenzene |
||||||||||
(106-46-7) |
10 |
|||||||||
Dichlorodifluoromethane |
||||||||||
(75-71-8) |
1,000 |
4,940 |
||||||||
1,4-Dichloro-2-butene |
||||||||||
(764-41-0) — Skin |
0.005 |
|||||||||
1,3-Dichloro-5,5-dimethyl-hydantoin |
||||||||||
(118-52-5) |
0.2 |
0.4 |
||||||||
1, 3-Dichloro-2-Propanol |
||||||||||
(96-23-1) — Skin |
1 |
5 |
||||||||
1,1-Dichloroethane |
||||||||||
(75-34-3) |
100 |
|||||||||
1,2-Dichloroethane |
||||||||||
(107-06-2) |
10 |
40 |
||||||||
1,1-Dichloroethene |
||||||||||
(75-35-4) |
1 |
4 |
20 |
80 |
||||||
1,2-Dichloroethylene |
||||||||||
(540-59-0) |
200 |
790 |
250 |
990 |
||||||
Dichloroethyne |
||||||||||
(7572-29-4) |
0.1 |
0.4 | ||||||||
Dichlorofluoromethane |
||||||||||
(75-43-4) |
10 |
42 |
||||||||
Dichloromethane |
||||||||||
(75-09-2) |
50 |
175 |
||||||||
1,1-Dichloro-1-nitroethane |
||||||||||
(594-72-9) |
2 |
12 |
||||||||
(2,4-Dichlorophenoxy) acetic acid and its esters (as 2,4-D) |
||||||||||
(94-75-7) |
10 |
|||||||||
2-(2,4-Dichlorophenoxy) ethanol hydrogen sulfate sodium salt |
||||||||||
(136-78-7) |
10 |
|||||||||
1,2-Dichloropropane |
||||||||||
(78-87-5) |
75 |
350 |
110 |
510 |
||||||
1,3-Dichloropropene |
||||||||||
(542-75-6) — Skin |
1 |
5 |
||||||||
2,2-Dichloropropionic acid, inhalable |
||||||||||
(75-99-0) |
5 |
|||||||||
1,2-Dichloro-1,1,2,2-tetra-fluoroethane |
||||||||||
(76-14-2) |
1,000 |
6,985 |
||||||||
Dichlorvos (DDVP), inhalable, vapour and aerosol |
||||||||||
(62-73-7) — Skin |
0.1 |
|||||||||
Dicrotophos, inhalable, vapour and aerosol |
||||||||||
(141-66-2) — Skin |
0.05 |
|||||||||
Dicyclopentadiene |
||||||||||
(77-73-6) |
5 |
27 |
||||||||
Dieldrin |
||||||||||
(60-57-1) — Skin |
0.25 |
|||||||||
Diesel fuel, as total hydrocarbons, vapour and aerosol |
||||||||||
(68334-30-5; 68476-30-2; 68476-31-3; 68476-34-6; 77650-28-3) — Skin |
100 |
|||||||||
Diethanolamine |
||||||||||
(111-42-2) |
2 |
|||||||||
Diethylamine |
||||||||||
(109-89-7) |
5 |
15 |
||||||||
2-Diethylaminoethanol |
||||||||||
(100-37-8) — Skin |
2 |
|||||||||
Diethylene glycol monoethyl ether |
||||||||||
(111-90-0) |
30 |
165 |
||||||||
Diethylene triamine |
||||||||||
(111-40-0) — Skin |
1 |
4 |
||||||||
Diethyl phthalate |
||||||||||
(84-66-2) |
5 |
|||||||||
1,2-Dihydroxybenzene |
||||||||||
(120-80-9) |
5 |
22 |
||||||||
1,4-Dihydroxybenzene |
||||||||||
(123-31-9) |
2 |
|||||||||
Diisodecyl phthalate |
||||||||||
(26761-40-0) |
5 |
|||||||||
Diisopropylamine |
||||||||||
(108-18-9) — Skin |
5 |
20 |
||||||||
Dimethoxymethane |
||||||||||
(109-87-5) |
1,000 |
3,110 |
||||||||
N,N-Dimethylacetamide |
||||||||||
(127-19-5) — Skin |
10 |
36 |
||||||||
Dimethylamine |
||||||||||
(124-40-3) |
5 |
15 |
||||||||
3-(Dimethylamino) propylamine |
||||||||||
(111-90-0) — Skin |
0.5 |
2 |
||||||||
N,N-Dimethylaniline |
||||||||||
(121-69-7) — Skin |
5 |
25 |
10 |
50 |
||||||
ar,ar-Dimethylbenzenamine (sum of all isomers), inhalable, vapour and aerosol, also known as Xylidine |
||||||||||
(1300-73-8) — Skin |
0.5 |
|||||||||
Dimethylbenzene (sum of o-, m- and p-isomers) |
||||||||||
(1330-20-7) |
100 |
435 |
150 |
650 |
||||||
N, N-Dimethyl-cyclohexylamine |
||||||||||
(98-94-2) |
5 |
26 |
||||||||
Dimethylethoxysilane |
||||||||||
(14857-34-2) |
0.5 |
1.5 |
||||||||
N, N-Dimethyl-ethanolamine |
||||||||||
(108-01-0) |
3 |
11 |
6 |
22 |
||||||
N,N-Dimethylformamide |
||||||||||
(68-12-2) — Skin |
10 |
30 |
||||||||
2,6-Dimethyl-4-heptanone |
||||||||||
(108-83-8) |
25 |
145 |
||||||||
1,1-Dimethylhydrazine |
||||||||||
(57-14-7) — Skin |
0.01 |
|||||||||
2-(2,2-Dimethyl-1-oxopropyl)-H-indene-1,3(2H)-dione |
||||||||||
(83-26-1) |
0.1 |
|||||||||
Dimethyl phthalate |
||||||||||
(131-11-3) |
5 |
|||||||||
Dimethyl sulfate |
||||||||||
(77-78-1) — Skin |
0.1 |
0.5 |
||||||||
Dimethyl sulfide |
||||||||||
(75-18-3) |
10 |
|||||||||
Dimethyl terephthalate |
||||||||||
(120-61-6) |
5 |
|||||||||
Dimethyl 2,3,5,6-tetracholorotere-phthalate |
||||||||||
(1861-32-1) |
5 |
|||||||||
Dinitrobenzene (sum of m-, o-, and p-isomers: |
||||||||||
(99-65-0), (528-29-0), and (100-25-4)) — Skin |
0.15 |
1.0 |
||||||||
Dinitro-o-cresol |
||||||||||
(534-52-1) — Skin |
0.2 |
|||||||||
Dinitrotoluene (sum of all isomers) |
||||||||||
(25321-14-6) — Skin |
0.2 |
|||||||||
1,4-Dioxane |
||||||||||
(123-91-1) — Skin |
20 |
|||||||||
Dioxathion, inhalable, vapour and aerosol |
||||||||||
(78-34-2) — Skin |
0.1 |
|||||||||
1,3-Dioxolane |
||||||||||
(646-06-0) |
20 |
|||||||||
N,N-Diphenylamine |
||||||||||
(122-39-4) |
10 |
|||||||||
Dipropylene glycol monomethyl ether |
||||||||||
(34590-94-8) |
100 |
605 |
150 |
910 |
||||||
Dipropylene glycol monomethyl ether acetate |
||||||||||
(88917-22-0) |
100 |
776 |
150 |
1,164 |
||||||
Diquat |
||||||||||
(2764-72-9) — Skin |
0.5 |
|||||||||
Diquat, respirable |
||||||||||
(2764-72-9) — Skin |
0.1 |
|||||||||
Disulfiram |
||||||||||
(97-77-8) |
2 |
|||||||||
Disulfoton, inhalable, vapour and aerosol |
||||||||||
(298-04-4) — Skin |
0.05 |
|||||||||
Diuron |
||||||||||
(330-54-1) |
10 |
|||||||||
m-Divinylbenzene |
||||||||||
(108-57-6) |
10 |
53 |
||||||||
Dodecyl mercaptan |
||||||||||
(112-55-0) |
0.1 |
|||||||||
Emery (total dust) |
||||||||||
(1302-74-5) |
10 |
|||||||||
Endosulfan |
||||||||||
(115-29-7) — Skin |
0.1 |
|||||||||
Endrin |
||||||||||
(72-20-8) — Skin |
0.1 |
|||||||||
Enflurane |
||||||||||
(13838-16-9) |
2 |
16 |
||||||||
1,2-Epoxy-4-(epoxyethyl)-cyclohexane |
||||||||||
(106-87-6) — Skin |
0.1 |
|||||||||
2,3-Epoxy-1-propanol |
||||||||||
(556-52-5) |
2 |
|||||||||
Ethane |
||||||||||
(74-84-0) |
1,000 |
|||||||||
Ethanethiol |
||||||||||
(75-08-1) |
0.5 |
1.3 |
||||||||
Ethanol |
||||||||||
(64-17-5) |
1,000 |
1,900 |
||||||||
Ethion, inhalable, vapour and aerosol |
||||||||||
(563-12-2) — Skin |
0.05 |
|||||||||
Ethoxyethane |
||||||||||
(60-29-7) |
400 |
1,210 |
500 |
1,515 |
||||||
2-Ethoxyethanol (EGEE) |
||||||||||
(110-80-5) — Skin |
5 |
18 |
||||||||
2-Ethoxyethyl acetate (EGEEA) |
||||||||||
(111-15-9) — Skin |
5 |
27 |
||||||||
Ethyl acetate |
||||||||||
(141-78-6) |
400 |
1,440 |
||||||||
Ethyl acrylate |
||||||||||
(140-88-5) — Skin |
5 |
15 |
||||||||
Ethylamine |
||||||||||
(75-04-7) |
5 |
15 |
||||||||
Ethylbenzene |
||||||||||
(100-41-4) |
100 |
435 |
125 |
540 |
||||||
Ethyl bromide |
||||||||||
(74-96-4) |
5 |
|||||||||
Ethyl tert-butyl ether (ETBE) |
||||||||||
(637-92-3) |
5 |
|||||||||
Ethyl chloride |
||||||||||
(75-00-3) |
100 |
|||||||||
Ethyl cyanoacrylate |
||||||||||
(7085-85-0) |
0.2 |
|||||||||
Ethyl-3-ethoxy propionate |
||||||||||
(763-69-9) |
50 |
300 |
||||||||
Ethylene |
||||||||||
(74-85-1) |
200 |
|||||||||
Ethylene glycol |
||||||||||
(107-21-1) |
100 | |||||||||
Ethylene glycol dimethyl ether |
||||||||||
(110-71-4) — Skin |
5 |
18 |
||||||||
Ethylene glycol dinitrate (EGDN) |
||||||||||
(628-96-6) — Skin |
0.05 |
0.31 |
||||||||
Ethylene glycol mono-n-propyl ether |
||||||||||
(2807-30-9) — Skin |
25 |
110 |
||||||||
Ethylene glycol mononitrate |
||||||||||
(16051-48-2) — Skin |
0.05 |
0.22 |
||||||||
5-Ethylidene-2-norbornene |
||||||||||
(16219-75-3) |
5 |
25 | ||||||||
Ethylenimine |
||||||||||
(151-56-4) — Skin |
0.5 |
0.9 |
||||||||
Ethyl formate |
||||||||||
(109-94-4) |
100 |
300 |
||||||||
2-Ethylhexanoic acid, inhalable, vapour and aerosol |
||||||||||
(149-57-5) |
5 |
|||||||||
Ethyl methacrylate |
||||||||||
(97-63-2) |
100 |
470 |
||||||||
N-Ethylmorpholine |
||||||||||
(100-74-3) — Skin |
5 |
23 |
||||||||
O-Ethyl O-p-nitrophenyl phenylphosphonothioate (EPN), inhalable |
||||||||||
(2104-64-5) — Skin |
0.1 |
|||||||||
Ethyl silicate |
||||||||||
(78-10-4) |
10 |
85 |
||||||||
Fenamiphos |
||||||||||
(22224-92-6) — Skin |
0.1 |
|||||||||
Fensulfothion, inhalable, vapour and aerosol |
||||||||||
(115-90-2) — Skin |
0.01 |
|||||||||
Fenthion |
||||||||||
(55-38-9) — Skin |
0.1 |
|||||||||
Ferbam |
||||||||||
(14484-64-1) |
10 |
|||||||||
Ferrovanadium dust |
||||||||||
(12604-58-9) |
1 |
3 |
||||||||
Fluorides (as fluoride) |
||||||||||
(16984-48-8) |
2.5 |
|||||||||
Fluorine |
||||||||||
(7782-41-4) |
1 |
1.6 |
2 |
3.1 |
||||||
Fonofos |
||||||||||
(944-22-9) — Skin |
0.1 |
|||||||||
Forane |
||||||||||
(26675-46-7) |
2 |
15 |
||||||||
Formaldehyde |
||||||||||
(50-00-0) |
1 |
1.5 |
2 |
3 |
||||||
Note: On December 31, 2007, Part 4 of the Schedule is amended by striking out, | ||||||||||
Formaldehyde |
||||||||||
(50-00-0) |
1 |
1.5 |
2 |
3 |
||||||
and substituting the following: | ||||||||||
Formaldehyde |
||||||||||
(50-00-0) |
1.0 |
1.5 |
||||||||
See: O. Reg. 607/05, ss. 5 (4), 8 (3). | ||||||||||
Formamide |
||||||||||
(75-12-7) — Skin |
10 |
15 |
||||||||
Formic acid |
||||||||||
(64-18-6) |
5 |
10 |
||||||||
Furfural |
||||||||||
(98-01-1) — Skin |
2 |
8 |
||||||||
Furfuryl alcohol |
||||||||||
(98-00-0) — Skin |
10 |
40 |
15 |
60 |
||||||
Gallium arsenide, respirable |
||||||||||
(1303-00-0) |
0.0003 |
|||||||||
Gasoline |
||||||||||
(86290-81-5) |
300 |
500 |
||||||||
Germanium tetrahydride |
||||||||||
(7782-65-2) |
0.2 |
0.63 |
||||||||
Glycerin mist |
||||||||||
(56-81-5) |
10 |
|||||||||
Glutaraldehyde |
||||||||||
(111-30-8), activated and inactivated |
0.05 |
|||||||||
Glyoxal, inhalable, vapour and aerosol |
||||||||||
(107-22-2) |
0.1 |
|||||||||
Grain dust (oats, wheat, barley) |
4 |
|||||||||
Grain dust, not otherwise classified (total dust) |
4 |
|||||||||
Graphite (all forms except graphite fibres), respirable |
||||||||||
(7782-42-5) |
2 |
|||||||||
Gypsum (total dust) |
||||||||||
(10101-41-4) |
10 |
|||||||||
Hafnium |
||||||||||
(7440-58-6) |
0.5 |
|||||||||
Halothane |
||||||||||
(151-67-7) |
2 |
16 |
||||||||
Heptachlor |
||||||||||
(76-44-8) and Heptachlor epoxide (1024-57-3) — Skin |
0.05 |
|||||||||
n-Heptane, also known as Heptane |
||||||||||
(142-82-5) |
400 |
1,635 |
500 |
2,045 |
||||||
2-Heptanone |
||||||||||
(110-43-0) |
25 |
115 |
||||||||
3-Heptanone |
||||||||||
(106-35-4) |
50 |
75 |
||||||||
4-Heptanone |
||||||||||
(123-19-3) |
50 |
233 |
||||||||
Heptyl acetate |
||||||||||
(90438-79-2) |
50 |
320 |
||||||||
Hexachlorobenzene |
||||||||||
(118-74-1) — Skin |
0.002 |
|||||||||
Hexachloro-1,3-butadiene |
||||||||||
(87-68-3) — Skin |
0.02 |
0.21 |
||||||||
Hexachlorocyclopentadiene |
||||||||||
(77-47-4) |
0.01 |
0.11 |
||||||||
Hexachloroethane |
||||||||||
(67-72-1) |
1 |
|||||||||
Hexachloronaphthalene |
||||||||||
(1335-87-1) — Skin |
0.2 |
|||||||||
Hexafluoroacetone |
||||||||||
(684-16-2) — Skin |
0.1 |
0.7 |
||||||||
Hexahydrophthalic anhydride, All isomers, inhalable, vapour and aerosol |
||||||||||
(85-42-7; 13149-00-3; 14166-21-3) |
0.005 | |||||||||
Hexahydro-1,3,5-trinitro-1,3,5-triazine |
||||||||||
(121-82-4) — Skin |
0.5 |
|||||||||
Hexamethylenetetramine (HMT) |
||||||||||
(100-97-0) |
0.35 |
2 |
||||||||
n-Hexane |
||||||||||
(110-54-3) |
50 |
176 |
||||||||
Hexane, other isomers of |
500 |
1,760 |
1,000 |
3,520 |
||||||
1,6-Hexanediamine |
||||||||||
(124-09-4) |
0.5 |
|||||||||
2-Hexanone |
||||||||||
(591-78-6) |
1 |
4 |
||||||||
1-Hexene |
||||||||||
(592-41-6) |
30 |
|||||||||
sec-Hexyl acetate |
||||||||||
(142-92-7) |
50 |
294 |
||||||||
Hexyl acetate (isomeric mixture) |
||||||||||
(88230-35-7) |
50 |
294 |
||||||||
Hexylene glycol |
||||||||||
(107-41-5) |
25 |
120 | ||||||||
Hydrazine |
||||||||||
(302-01-2) — Skin |
0.01 |
|||||||||
Hydrogenated terphenyls1 |
||||||||||
(61788-32-7) |
0.5 |
|||||||||
Hydrogen bromide |
||||||||||
(10035-10-6) |
2 |
|||||||||
Hydrogen chloride |
||||||||||
(7647-01-0) |
5 |
7.4 | ||||||||
Note: On March 1, 2006, Part 4 of the Schedule is amended by striking out, | ||||||||||
Hydrogen chloride |
||||||||||
(7647-01-0) |
5 |
7.4 | ||||||||
and substituting the following: | ||||||||||
Hydrogen chloride |
||||||||||
(7647-01-0) |
2 |
|||||||||
See: O. Reg. 16/05, ss. 1 (3), 2 (3). | ||||||||||
Hydrogen cyanide and Cyanide salts, as CN |
||||||||||
Hydrogen cyanide |
||||||||||
(74-90-8) — Skin |
4.7 |
|||||||||
Calcium cyanide |
||||||||||
(592-01-8) — Skin |
5 | |||||||||
Potassium cyanide |
||||||||||
(151-50-8) — Skin |
5 | |||||||||
Sodium cyanide |
||||||||||
(143-33-9) — Skin |
5 | |||||||||
Hydrogen fluoride (as F) |
||||||||||
(7664-39-3) |
0.5 |
2 |
||||||||
Hydrogen peroxide |
||||||||||
(7722-84-1) |
1 |
1.4 |
||||||||
Hydrogen selenide (as selenium) |
||||||||||
(7783-07-5) |
0.05 |
0.16 |
||||||||
Hydrogen sulfide |
||||||||||
(7783-06-4) |
10 |
14 |
15 |
21 |
||||||
4-Hydroxy-4-methyl-2-pentanone |
||||||||||
(123-42-2) |
50 |
240 |
75 |
360 |
||||||
2-Hydroxypropyl acrylate |
||||||||||
(999-61-1) — Skin |
0.5 |
2.7 |
||||||||
Indene |
||||||||||
(95-13-6) |
10 |
47 |
||||||||
Indium and its compounds (as indium) |
||||||||||
(7440-74-6) |
0.1 |
|||||||||
Iodine |
||||||||||
(7553-56-2) |
0.1 |
1 | ||||||||
Iodoform |
||||||||||
(75-47-8) |
0.6 |
10 |
||||||||
Iron oxide (Fe2O3) dust and fume (as Fe) |
||||||||||
(1309-37-1) |
5 |
|||||||||
Iron pentacarbonyl (as iron) |
||||||||||
(13463-40-6) |
0.1 |
0.8 |
0.2 |
1.6 |
||||||
Iron salts, water-soluble (as iron) |
||||||||||
(7439-89-6) |
1 |
|||||||||
Isoamyl alcohol |
||||||||||
(123-51-3) |
100 |
360 |
125 |
450 |
||||||
Isobutyl acetate |
||||||||||
(110-19-0) |
150 |
710 |
187 |
887 |
||||||
Isobutyl alcohol |
||||||||||
(78-83-1) |
50 |
150 |
||||||||
Isobutyl nitrite, inhalable, vapour and aerosol |
||||||||||
(542-56-3) |
1 |
|||||||||
Isooctyl alcohol |
||||||||||
(26952-21-6) — Skin |
270 |
|||||||||
2-Isopropoxyethanol |
||||||||||
(109-59-1) |
25 |
105 |
||||||||
Isopropanol, also known as Isopropyl alcohol |
||||||||||
(67-63-0) |
200 |
400 |
||||||||
Isopropyl acetate |
||||||||||
(108-21-4) |
100 |
200 |
||||||||
Isopropylamine |
||||||||||
(75-31-0) |
5 |
12 |
10 |
24 |
||||||
Isopropylaminoethanols |
400 |
1,900 |
||||||||
N-Isopropylaniline |
||||||||||
(768-52-5) — Skin |
2 |
11 |
||||||||
Isosorbide dinitrate |
||||||||||
(87-33-2) — Skin |
0.2 |
|||||||||
Kaolin, respirable |
||||||||||
(1332-58-7) |
2(D) |
|||||||||
Kerosene, as total hydrocarbon vapour |
||||||||||
(8008-20-6; 64742-81-0/Jet fuels) — Skin |
200 (G) |
|||||||||
Ketene |
||||||||||
(463-51-4) |
0.5 |
0.9 |
1.5 |
2.6 |
||||||
L.P.G. (Liquified petroleum gas) |
||||||||||
(68476-85-7) |
1,000 |
|||||||||
Lead chromate |
||||||||||
(7758-97-6), as Cr |
0.012 |
|||||||||
Limestone (total dust) |
||||||||||
(1317-65-3) |
10(D) |
|||||||||
Lincomycin |
||||||||||
(154-21-2) |
0.1 |
|||||||||
Lindane |
||||||||||
(58-89-9) — Skin |
0.5 |
|||||||||
Lithium hydride |
||||||||||
(7580-67-8) |
0.025 |
|||||||||
Lithium hydroxide, Anyhydrous |
||||||||||
(1310-65-2) |
1 |
|||||||||
Lithium hydroxide, Monohydrate |
||||||||||
(1310-66-3) |
1 |
|||||||||
Magnesite (total dust) |
||||||||||
(546-93-0) |
10(D) |
|||||||||
Magnesium oxide, inhalable |
||||||||||
(1309-48-4) |
10 |
|||||||||
Malathion, inhalable, vapour and aerosol |
||||||||||
(121-75-5) — Skin |
1 |
|||||||||
Maleic anhydride |
||||||||||
(108-31-6) |
0.1 |
|||||||||
Manganese, and inorganic compounds (as manganese) |
||||||||||
(7439-96-5) |
0.2 |
|||||||||
Manganese cyclo-pentadienyltricarbonyl (as manganese) |
||||||||||
(12079-65-1) — Skin |
0.1 |
|||||||||
Manganese tetroxide (as manganese) |
||||||||||
(1317-35-7) — Skin |
1 |
|||||||||
Mesityl oxide |
||||||||||
(141-79-7) |
15 |
60 |
25 |
100 |
||||||
Methacrylic acid |
||||||||||
(79-41-4) |
20 |
70 |
||||||||
Methane |
||||||||||
(74-82-8) |
1000 |
|||||||||
Methanethiol |
||||||||||
(74-93-1) |
0.5 |
1 |
||||||||
Methanol |
||||||||||
(67-56-1) — Skin |
200 |
260 |
250 |
325 |
||||||
Methomyl |
||||||||||
(16752-77-5) |
2.5 |
|||||||||
Methoxychlor |
||||||||||
(72-43-5) |
10 |
|||||||||
2-Methoxyethanol (EGME) |
||||||||||
(109-86-4) — Skin |
5 |
16 |
||||||||
2-Methoxyethyl acetate (EGMEA) |
||||||||||
(110-49-6) — Skin |
5 |
24 |
||||||||
Methoxyflurane |
||||||||||
(76-38-0) |
2 |
13 |
||||||||
4-Methoxyphenol |
||||||||||
(150-76-5) |
5 |
|||||||||
1-Methoxy-2-propanol (PGME) |
||||||||||
(107-98-2) |
100 |
365 |
150 |
550 |
||||||
Methyl acetate |
||||||||||
(79-20-9) |
200 |
605 |
250 |
755 |
||||||
Methyl acetylene-propadiene mixture |
||||||||||
(MAPP) |
1,000 |
1,250 |
||||||||
Methyl acrylate |
||||||||||
(96-33-3) — Skin |
2 |
|||||||||
Methylamine |
||||||||||
(74-89-5) |
5 |
15 |
||||||||
N-Methylbenzenamine |
||||||||||
(100-61-8) — Skin |
0.5 |
2.2 |
||||||||
Methylbenzene |
||||||||||
(108-88-3) |
50 |
|||||||||
Methyl bromide |
||||||||||
(74-83-9) — Skin |
1 |
|||||||||
3-Methyl-2-butanone |
||||||||||
(563-80-4) |
200 |
705 |
||||||||
Methyl tert-butyl ether (MTBE) |
||||||||||
(1634-04-4) |
40 |
|||||||||
Methyl chloride |
||||||||||
(74-87-3) |
50 |
103 |
100 |
205 |
||||||
Methyl 2-cyanoacrylate |
||||||||||
(137-05-3) |
0.2 |
|||||||||
Methylcyclohexane |
||||||||||
(108-87-2) |
400 |
1,600 |
||||||||
2-Methylcyclohexanol |
||||||||||
(583-59-5) |
50 |
233 |
||||||||
2-Methylcyclohexanone |
||||||||||
(583-60-8) — Skin |
50 |
230 |
75 |
345 |
||||||
2-Methylcyclopentadienyl-manganese tricarbonyl (as manganese) |
||||||||||
(12108-13-3) — Skin |
0.2 |
|||||||||
Methyl demeton |
||||||||||
(8022-00-2) — Skin |
0.5 |
|||||||||
2-Methyl-3,5-dinitrobenzamide |
||||||||||
(148-01-6) |
5 |
10 |
||||||||
Methylene bis (4-cyclohexyl isocyanate) |
||||||||||
(5124-30-1) |
0.005 |
|||||||||
4,4´-Methylene bis (2-chloroaniline) |
||||||||||
(101-14-4) — Skin |
0.0005 |
0.005 |
||||||||
4,4´-Methylene-dianiline |
||||||||||
(101-77-9) — Skin |
0.04 |
|||||||||
((1-Methylethoxy)methyl)-oxirane |
||||||||||
(4016-14-2) |
50 |
237 |
75 |
356 |
||||||
Methyl ethyl ketone peroxides |
0.2 |
1.5 | ||||||||
Methyl formate |
||||||||||
(107-31-3) |
100 |
245 |
150 |
370 |
||||||
5-Methyl-3-heptanone |
||||||||||
(541-85-5) |
25 |
130 |
||||||||
5-Methyl-2-hexanone |
||||||||||
(110-12-3) |
50 |
233 |
||||||||
Methylhydrazine |
||||||||||
(60-34-4) — Skin |
0.01 |
|||||||||
Methyl iodide |
||||||||||
(74-88-4) — Skin |
2 |
12 |
||||||||
Methyl methacrylate |
||||||||||
(80-62-6) |
50 |
100 |
||||||||
Methyl parathion |
||||||||||
(298-00-0) — Skin |
0.2 |
|||||||||
4-Methyl-2-pentanol |
||||||||||
(108-11-2) — Skin |
25 |
104 |
40 |
167 |
||||||
4-Methyl-2-pentanone |
||||||||||
(108-10-1) |
50 |
205 |
75 |
|||||||
2-Methyl-2-propenenitrile |
||||||||||
(126-98-7) — Skin |
1 |
2.7 |
||||||||
N-Methyl-2-pyrrolidone |
||||||||||
(872-50-4) |
400 |
|||||||||
alpha-Methylstyrene |
||||||||||
(98-83-9) |
50 |
241 |
100 |
482 |
||||||
1-Methyl-2,4,6-trinitrobenzene |
||||||||||
(118-96-7) — Skin |
0.01 |
0.1 |
0.02 |
0.2 |
||||||
Methyl vinyl ketone |
||||||||||
(78-94-4) — Skin |
0.2 |
|||||||||
Metribuzin |
||||||||||
(21087-64-9) |
5 |
|||||||||
Mevinphos, inhalable, vapour and aerosol |
||||||||||
(7786-34-7) — Skin |
0.01 |
|||||||||
Mica, respirable |
||||||||||
(12001-26-2) |
3(D) |
|||||||||
Mineral Spirits |
525 |
|||||||||
Molybdenum metal, dioxide and disulfide (as molybdenum) |
||||||||||
(7439-98-7) |
10 |
|||||||||
Molybdenum trioxide and molybdates (as molybdenum) |
||||||||||
(7439-98-7) |
5 |
|||||||||
Note: On March 1, 2006, Part 4 of the Schedule is amended by striking out, | ||||||||||
Molybdenum metal, dioxide and disulfide (as molybdenum) |
||||||||||
(7439-98-7) |
10 |
|||||||||
Molybdenum trioxide and molybdates (as molybdenum) |
||||||||||
(7439-98-7) |
5 |
|||||||||
and substituting the following: | ||||||||||
Molybdenum, as molybdenum |
||||||||||
(7439-98-7) |
||||||||||
Metal and insoluble compounds |
||||||||||
- inhalable |
10 |
|||||||||
- respirable |
3 |
|||||||||
Soluble compounds |
||||||||||
-respirable |
0.5 |
|||||||||
See: O. Reg. 16/05, ss. 1 (3), 2 (3). | ||||||||||
Monocrotophos, inhalable, vapour and aerosol |
||||||||||
(6923-22-4) — Skin |
0.05 |
|||||||||
Morpholine |
||||||||||
(110-91-8) — Skin |
20 |
70 |
30 |
105 |
||||||
Naled, inhalable, vapour and aerosol |
||||||||||
(300-76-5) — Skin |
0.1 |
|||||||||
Naphthalene |
||||||||||
(91-20-3) |
10 |
52 |
15 |
78 |
||||||
1-Naphthyl N-methyl-carbamate |
||||||||||
(63-25-2) |
5 |
|||||||||
alpha-Naphthylthiourea |
||||||||||
(86-88-4) |
0.3 |
|||||||||
Natural gas |
||||||||||
(8006-14-2) |
1000 |
|||||||||
Natural rubber latex, as Total proteins, inhalable |
||||||||||
(9006-04-6) — Skin |
0.001 |
|||||||||
Nepheline syenite (total dust) |
||||||||||
(37244-96-5) |
10 |
|||||||||
Nickel carbonyl (as nickel) |
||||||||||
(13463-39-3) |
0.05 |
0.35 |
||||||||
Nickel, elemental/metal, inhalable |
||||||||||
(7440-02-0) |
1 |
|||||||||
Nickel, insoluble compounds, as Ni, inhalable |
||||||||||
(7440-02-0) |
0.2 |
|||||||||
Nickel, soluble compounds, as Ni, inhalable |
||||||||||
(7440-02-0) |
0.1 |
|||||||||
Nickel subsulfide, inhalable, as Ni |
||||||||||
(12035-72-2) |
0.1 |
|||||||||
Nicotine |
||||||||||
(54-11-5) — Skin |
0.5 |
|||||||||
Nitramine |
||||||||||
(479-45-8) — Skin |
1.5 |
|||||||||
Nitric acid |
||||||||||
(7697-37-2) |
2 |
5 |
4 |
10 |
||||||
Nitric oxide |
||||||||||
(10102-43-9) |
25 |
31 |
||||||||
p-Nitroaniline |
||||||||||
(100-01-6) — Skin |
3 |
|||||||||
Nitrobenzene |
||||||||||
(98-95-3) — Skin |
1 |
5 |
||||||||
Nitroethane |
||||||||||
(79-24-3) |
100 |
306 |
||||||||
Nitrogen dioxide |
||||||||||
(10102-44-0) |
3 |
5.6 |
5 |
9.4 |
||||||
Nitrogen trifluoride |
||||||||||
(7783-54-2) |
10 |
29 |
||||||||
Nitroglycerine (NG) |
||||||||||
(55-63-0) — Skin |
0.05 |
0.5 |
||||||||
Nitromethane |
||||||||||
(75-52-5) |
20 |
|||||||||
1-Nitropropane |
||||||||||
(108-03-2) |
25 |
90 |
||||||||
2-Nitropropane |
||||||||||
(79-46-9) |
1 |
35 |
20 |
70 |
||||||
Nitrotoluene (sum of m-, o-, and p-isomers: |
||||||||||
(99-08-1), (88-72-2), and (99-99-0)) — Skin |
2 |
11 |
||||||||
Nitrous oxide |
||||||||||
(10024-97-2) |
25 |
45 |
||||||||
Nonane |
||||||||||
(111-84-2) |
200 |
1,050 |
||||||||
Octachloronaphthalene |
||||||||||
(2234-13-1) — Skin |
0.1 |
0.3 |
||||||||
Octane |
||||||||||
(111-65-9) |
300 |
1,400 |
375 |
1,750 |
||||||
Oil, mineral — Mist |
||||||||||
(8012-95-1) |
5 |
10 |
||||||||
Osmium tetroxide (as osmium) |
||||||||||
(20816-12-0) |
0.0002 |
0.002 |
0.0006 |
0.006 |
||||||
Oxalic acid |
||||||||||
(144-62-7) |
1 |
2 |
||||||||
1,1´-Oxybisbenzene |
||||||||||
(101-84-8) |
1 |
7 |
2 |
14 |
||||||
p,p´-Oxybis(benzenesulfonyl hydrazide), inhalable |
||||||||||
(80-51-3) |
0.1 |
|||||||||
1,1´-Oxybis(2-chloroethane) |
||||||||||
(111-44-4) — Skin |
5 |
29 |
10 |
58 |
||||||
Oxybis (chloromethane) |
||||||||||
(542-88-1) |
0.001 |
0.005 |
||||||||
2,2´-(Oxybis(methylene))-bisoxirane |
||||||||||
(2238-07-5) |
0.1 |
0.53 |
||||||||
2,2´-Oxybis(propane) |
||||||||||
(108-20-3) |
250 |
1,045 |
310 |
1,295 |
||||||
Oxygen difluoride |
||||||||||
(7783-41-7) |
0.05 |
0.1 | ||||||||
Ozone |
||||||||||
(10028-15-6) |
0.1 |
0.2 |
0.3 |
0.6 |
||||||
Paraffin wax fume |
||||||||||
(8002-74-2) |
2 |
|||||||||
Paraquat |
||||||||||
(1910-42-5) |
0.1 |
|||||||||
Parathion, inhalable, vapour and aerosol |
||||||||||
(56-38-2) — Skin |
0.05 |
|||||||||
Particles (insoluble or poorly soluble) Not Otherwise Specified (PNOS) |
||||||||||
- inhalable particulate |
10 |
|||||||||
- respirable particulate |
3 |
|||||||||
Penicillin (total dust) |
||||||||||
(1406-05-9) |
0.1 |
|||||||||
Pentaborane |
||||||||||
(19624-22-7) |
0.005 |
0.013 |
0.015 |
0.039 |
||||||
Pentachloronaphthalene |
||||||||||
(1321-64-8) |
0.5 |
|||||||||
Pentachloronitrobenzene |
||||||||||
(82-68-8) |
0.5 |
|||||||||
Pentachlorophenol |
||||||||||
(87-86-5) — Skin |
0.5 |
|||||||||
Pentaerythritol (total dust) |
||||||||||
(115-77-5) |
10 |
|||||||||
Pentaerythritol tetrabenzoate |
||||||||||
(4196-86-5) |
2 |
|||||||||
Pentane |
||||||||||
(109-66-0) |
600 |
1,770 |
750 |
2,210 |
||||||
2-Pentanone |
||||||||||
(107-87-9) |
200 |
700 |
250 |
880 |
||||||
3-Pentanone |
||||||||||
(96-22-0) |
200 |
300 |
||||||||
Pentyl acetate, All isomers |
||||||||||
(628-63-7, n-Amyl acetate; 626-38-0, Sec-amyl acetate; 123-92-2, Isoamyl acetate; 625-16-1; 624-41-9; 620-11-1) |
50 |
100 |
||||||||
Perchloryl fluoride |
||||||||||
(7616-94-6) |
3 |
13 |
6 |
25 |
||||||
Perfluorobutyl ethylene |
||||||||||
(19430-93-4) |
100 |
|||||||||
Perfluoroisobutylene |
||||||||||
(382-21-8) |
0.01 |
|||||||||
Perlite (a) |
10(D) |
|||||||||
Persulfates, ammonium (7727-54-1), sodium (7775-27-1) and potassium persulfates (7727-21-1) |
0.1 |
|||||||||
Petroleum ether |
500 |
|||||||||
Petroleum coke (total dust) |
||||||||||
(64741-79-3) |
3.5(A) |
|||||||||
Phenol |
||||||||||
(108-95-2) — Skin |
5 |
19 |
||||||||
Phenothiazine |
||||||||||
(92-84-2) — Skin |
5 |
|||||||||
2-Phenoxyethanol |
||||||||||
(122-99-6) — Skin |
25 |
141 |
||||||||
(Phenoxymethyl)oxirane, also known as Phenyl glycidyl ether (PGE) — Skin |
||||||||||
(122-60-1) |
0.1 |
|||||||||
o-Phenylenediamine |
||||||||||
(95-54-5) |
0.1 |
|||||||||
m-Phenylenediamine |
||||||||||
(108-45-2) |
0.1 |
|||||||||
p-Phenylenediamine |
||||||||||
(106-50-3) — Skin |
0.1 |
|||||||||
Phenylhydrazine |
||||||||||
(100-63-0) — Skin |
0.1 |
|||||||||
Phenyl mercaptan, also known as Benzenethiol |
||||||||||
(108-98-5) — Skin |
0.1 |
|||||||||
Phenylphosphine |
||||||||||
(638-21-1) |
0.05 |
0.23 | ||||||||
Phorate, inhalable, vapour and aerosol |
||||||||||
(298-02-2) — Skin |
0.05 |
|||||||||
Phosphine |
||||||||||
(7803-51-2) |
0.3 |
0.4 |
1 |
1.4 |
||||||
Phosphoric acid |
||||||||||
(7664-38-2) |
1 |
3 |
||||||||
Phosphorus (yellow) |
||||||||||
(12185-10-3) |
0.1 |
|||||||||
Phosphorus oxychloride |
||||||||||
(10025-87-3) |
0.1 |
0.6 |
0.5 |
3 |
||||||
Phosphorus pentachloride |
||||||||||
(10026-13-8) |
0.1 |
0.85 |
||||||||
Phosphorus pentasulfide |
||||||||||
(1314-80-3) |
1 |
3 |
||||||||
Phosphorus trichloride |
||||||||||
(7719-12-2) |
0.2 |
1.1 |
0.5 |
2.8 |
||||||
Phthalic anhydride |
||||||||||
(85-44-9) |
1 |
6 |
||||||||
m-Phthalodinitrile |
||||||||||
(626-17-5) |
5 |
|||||||||
Piperazine dihydrochloride |
||||||||||
(142-64-3) |
5 |
|||||||||
Platinum metal |
||||||||||
(7440-06-4) |
1 |
|||||||||
Platinum, water-soluble compounds of, including chloroplatinates (as platinum) |
||||||||||
(7440-06-4) |
0.002 |
|||||||||
Polychlorinated biphenyls (PCBs)1 |
0.05 |
|||||||||
Portland cement (total dust) |
||||||||||
(65997-15-1) |
10(D) |
|||||||||
Potassium hydroxide |
||||||||||
(1310-58-3) |
2 | |||||||||
Poultry dust (total dust) |
5 |
|||||||||
Precipitated silica (total dust) |
||||||||||
(1309-37-1) |
10 |
|||||||||
Propane |
||||||||||
(74-98-6) |
1,000 |
|||||||||
n-Propanol, also known as n-Propyl alcohol |
||||||||||
(71-23-8) |
200 |
490 |
250 |
615 |
||||||
Propargyl alcohol |
||||||||||
(107-19-7) — Skin |
1 |
2.3 |
||||||||
((2-Propenyloxy) methyl) oxirane |
||||||||||
(106-92-3) — Skin |
1 |
|||||||||
beta-Propiolactone |
||||||||||
(57-57-8) |
0.5 |
1.5 |
||||||||
Propionaldehyde |
||||||||||
(123-38-6) |
20 |
|||||||||
Propionic acid |
||||||||||
(79-09-4) |
10 |
30 |
||||||||
Propoxur |
||||||||||
(114-26-1) |
0.5 |
|||||||||
n-Propyl acetate |
||||||||||
(109-60-4) |
200 |
830 |
250 |
1,040 |
||||||
1,2-Propylene glycol dinitrate |
||||||||||
(6423-43-4) — Skin |
0.05 |
0.34 |
||||||||
1,2-Propylene glycol, total vapour and aerosol |
||||||||||
(57-55-6) |
50 |
155 |
||||||||
1,2-Propylene glycol, aerosol only |
||||||||||
(57-55-6) |
10(C) |
|||||||||
Propylene glycol monomethyl ether acetate |
||||||||||
(108-65-6) |
50 |
270 |
||||||||
Propylene oxide, also known as 1,2-Epoxypropane |
||||||||||
(75-56-9) |
2 |
|||||||||
Propylenimine |
||||||||||
(75-55-8) — Skin |
2 |
4.7 |
||||||||
n-Propyl nitrate |
||||||||||
(627-13-4) |
25 |
105 |
40 |
170 |
||||||
Propyne |
||||||||||
(74-99-7) |
1,000 |
1,635 |
1,250 |
2,045 |
||||||
Pyrethrum |
||||||||||
(8003-34-7) |
5 |
|||||||||
Pyridine |
||||||||||
(110-86-1) |
1 |
|||||||||
Quinone |
||||||||||
(106-51-4) |
0.1 |
0.44 |
||||||||
Resorcinol |
||||||||||
(108-46-3) |
10 |
45 |
20 |
90 |
||||||
Rhodium, metal and water-insoluble compounds of (as rhodium) |
||||||||||
(7440-16-6) |
1 |
|||||||||
Rhodium, water-soluble compounds of, including chloride, nitrate, and sulfate (as rhodium) |
||||||||||
(7440-16-6) |
0.01 |
|||||||||
Ronnel |
||||||||||
(299-84-3) |
10 |
|||||||||
Rotenone (commercial) |
||||||||||
(83-79-4) |
5 |
|||||||||
Rouge (total dust) |
||||||||||
(1309-37-1) |
10(D) |
|||||||||
Rubber solvent1 |
1,600 |
|||||||||
Selenium and its compounds except selenium hexafluoride and hydrogen selenide (as selenium) |
||||||||||
(7782-49-2) |
0.2 |
|||||||||
Selenium hexafluoride (as selenium) |
||||||||||
(7783-79-1) |
0.025 |
0.1 |
||||||||
Shellac dust (total dust) |
||||||||||
(9000-59-3) |
10 |
|||||||||
Silane |
||||||||||
(7803-62-5) |
5 |
6.6 |
||||||||
Silica fume, respirable |
||||||||||
(69012-64-2) |
2 |
|||||||||
Silica fused, respirable |
||||||||||
(60676-86-0) |
0.1 |
|||||||||
Silica gel |
||||||||||
(112926-00-8) |
10 |
|||||||||
Silicon (total dust) |
||||||||||
(7440-21-3) |
10 |
|||||||||
Silicon carbide |
||||||||||
(409-21-2) |
||||||||||
Nonfibrous - inhalable |
10(D) |
|||||||||
- respirable |
3 (D) |
|||||||||
Fibrous (including whiskers) |
||||||||||
- respirable |
0.1 f/cc (F) |
|||||||||
Silver, metal |
||||||||||
(7440-22-4) |
0.1 |
|||||||||
Silver, water-soluble compounds of (as silver) |
||||||||||
(7440-22-4) |
0.01 |
|||||||||
Sisal dust (total dust) |
2 |
|||||||||
Soap dust |
||||||||||
(68918-36-5) |
5 |
|||||||||
Soapstone, total dust |
6(D) |
|||||||||
Soapstone, respirable |
3(D) |
|||||||||
Sodium azide |
||||||||||
(26628-22-8) |
0.1 |
0.26 | ||||||||
Sodium bisulfite |
||||||||||
(7631-90-5) |
5 |
|||||||||
Sodium fluoroacetate |
||||||||||
(62-74-8) — Skin |
0.05 |
0.15 |
||||||||
Sodium hydroxide |
||||||||||
(1310-73-2) |
2 | |||||||||
Sodium metabisulfite |
||||||||||
(7681-57-4) |
5 |
|||||||||
Spectinomycin |
2 |
|||||||||
Starch (total dust) |
||||||||||
(9005-25-8) |
10 |
|||||||||
Stearates (total dust) |
10 |
|||||||||
Stoddard solvent1 |
||||||||||
(8052-41-3) |
525 |
|||||||||
140 Degree C Flash Aliphatic Solvent, Type of Stoddard Solvent |
525 |
|||||||||
Strontium chromate, as Cr |
||||||||||
(7789-06-2) |
0.0005 |
|||||||||
Strychnine |
||||||||||
(57-24-9) |
0.15 |
|||||||||
Styrene* |
||||||||||
(100-42-5) |
50 |
213 |
200 |
852 |
||||||
Note: On March 1. 2006, Part 4 of the Schedule is amended by striking out, | ||||||||||
Styrene* |
||||||||||
(100-42-5) |
50 |
213 |
200 |
852 |
||||||
and substituting the following: | ||||||||||
Styrene* |
||||||||||
(100-42-5) |
50 |
100 |
||||||||
See: O. Reg. 607/05, ss. 5 (3), 8 (2). | ||||||||||
Note: On December 31, 2007, Part 4 of the Schedule is amended by striking out, | ||||||||||
Styrene* |
||||||||||
(100-42-5) |
50 |
100 |
||||||||
and substituting the following: | ||||||||||
Styrene |
||||||||||
(100-42-5) |
35 |
100 |
||||||||
See: O. Reg. 607/05, ss. 5 (4), 8 (3). | ||||||||||
Sucrose (total dust) |
||||||||||
(57-50-1) |
10 |
|||||||||
Subtilisins (proteolytic enzymes as 100% pure crystalline enzyme) |
||||||||||
(9014-01-1) |
0.00006 | |||||||||
Sulfometuron methyl |
||||||||||
(74222-97-2) |
5 |
|||||||||
Sulfotepp, inhalable, vapour and aerosol, also known as Tetraethyl dithiono-pyrophosphate(TEDP) |
||||||||||
(3689-24-5) — Skin |
0.1 |
|||||||||
Sulfur dioxide |
||||||||||
(7446-09-5) |
2 |
5.2 |
5 |
10.4 |
||||||
Sulfur hexafluoride |
||||||||||
(2551-62-4) |
1,000 |
5,970 |
||||||||
Sulfuric acid, thoracic |
||||||||||
(7664-93-9) |
0.2 |
|||||||||
Sulfur monochloride |
||||||||||
(10025-67-9) |
1 |
6 | ||||||||
Sulfur pentafluoride |
||||||||||
(5714-22-7) |
0.01 |
0.1 | ||||||||
Sulfur tetrafluoride |
||||||||||
(7783-60-0) |
0.1 |
0.4 | ||||||||
Sulfuryl fluoride |
||||||||||
(2699-79-8) |
5 |
21 |
10 |
42 |
||||||
Sulprofos |
||||||||||
(35400-43-2) |
1 |
|||||||||
Synthetic Vitreous Fibres (Man made Mineral Fibres) |
||||||||||
- Continuous filament glass fibres, inhalable |
5 |
|||||||||
- Continuous filament glass fibres |
1f/cc(H) |
|||||||||
- Glass wool fibres |
1f/cc(H) |
|||||||||
- Refractory ceramic fibres |
0.5f/cc(H) |
|||||||||
- Rock wool fibres |
1f/cc(H) |
|||||||||
- Slag wool fibres |
1f/cc(H) |
|||||||||
- Special purpose glass fibres |
1f/cc(H) |
|||||||||
- Synthetic vitreous fibres, not otherwise classified (excluding fibrous glass dust and mineral wool fibre) |
1f/cc(E)(H) |
|||||||||
Talc (containing no asbestos fibres), respirable |
||||||||||
(14807-96-6) |
2(D) |
|||||||||
Talc (containing fibres other than those of asbestos and tremolite asbestos) |
2f/cc(B) |
|||||||||
Tantalum, metal and oxide (total dust) |
||||||||||
(7440-25-7) |
10 |
|||||||||
Tellurium and its compounds except tellurium hexafluoride (as tellurium) |
||||||||||
(13494-80-9) |
0.1 |
|||||||||
Tellurium hexafluoride (as tellurium) |
||||||||||
(7783-80-4) |
0.01 |
0.1 |
||||||||
Temephos, inhalable, vapour and aerosol |
||||||||||
(3383-96-8) — Skin |
1 |
|||||||||
Terbufos, inhalable, vapour and aerosol |
||||||||||
(13071-79-9) — Skin |
0.01 |
|||||||||
Terephthalic acid |
||||||||||
(100-21-0) |
10 |
|||||||||
Terphenyls (sum of o-, m-, and p-isomers) |
||||||||||
(84-15-1), (92-06-8), (92-94-4) |
0.5 |
4.7 | ||||||||
1,1,2,2-Tetrabromoethane |
||||||||||
(79-27-6) |
1 |
14 |
||||||||
1,1,1,2-Tetrachloro-2,2-difluoroethane |
||||||||||
(76-11-9) |
500 |
4,165 |
||||||||
1,1,2,2-Tetrachloro-1,2-difluoroethane |
||||||||||
(76-12-0) |
500 |
4,165 |
||||||||
1,1,2,2-Tetrachloroethane |
||||||||||
(79-34-5) — Skin |
1 |
7 |
||||||||
Tetrachloroethylene |
||||||||||
(127-18-4) |
25 |
100 |
||||||||
Tetrachloronaphthalene |
||||||||||
(1335-88-2) |
2 |
|||||||||
Tetrachlorophathalic anhydride |
||||||||||
(117-08-8) |
0.1 |
|||||||||
Tetrachlorophenol |
||||||||||
(25167-83-3) — Skin |
0.5 |
|||||||||
Tetraethyl pyrophosphate |
||||||||||
(107-49-3) — Skin |
0.004 |
0.047 |
||||||||
Tetrafluoroethylene |
||||||||||
(116-14-3) |
2 |
|||||||||
Tetrahydrofuran |
||||||||||
(109-99-9) |
200 |
590 |
250 |
735 |
||||||
Tetrakis (hydroxymethyl) phosphonium salts |
||||||||||
- Tetrakis (hydroxymethyl) phosphonium chloride |
||||||||||
(124-64-1) |
2 |
|||||||||
- Tetrakis (hydroxymethyl) phosphonium sulphate |
||||||||||
(55566-30-8) |
2 |
|||||||||
Tetramethoxysilane |
||||||||||
(681-84-5) |
1 |
6.2 |
||||||||
Tetramethylsuccino-dinitrile |
||||||||||
(3333-52-6) — Skin |
0.5 |
2.8 |
||||||||
Tetranitromethane |
||||||||||
(509-14-8) |
0.005 |
|||||||||
Tetrasodium pyrophosphate |
||||||||||
(7722-88-5) |
5 |
|||||||||
Thallium, water-soluble compounds of (as thallium) |
||||||||||
(7440-28-0) — Skin |
0.1 |
|||||||||
4,4´-Thiobis(6-tert-butyl-m-cresol) |
||||||||||
(96-69-5) |
10 |
|||||||||
Thioglycolic acid |
||||||||||
(68-11-1) — Skin |
1 |
3.8 |
||||||||
Thionyl chloride |
||||||||||
(7719-09-7) |
1 |
5 | ||||||||
Tin, metal, oxide and inorganic compounds of, except stannane (as tin) |
||||||||||
(7440-31-5) |
2 |
|||||||||
Tin, organic compounds of (as tin) |
||||||||||
(7440-31-5) — Skin |
0.1 |
|||||||||
Titanium dioxide (total dust) |
||||||||||
(13463-67-7) |
10 |
|||||||||
Toluidine (sum of o-, m- and p-isomers: |
||||||||||
(95-53-4), (108-44-1), and (108-49-0)) — Skin |
2 |
9 |
||||||||
Toxaphene1 |
||||||||||
(8001-35-2) — Skin |
0.5 |
1 |
||||||||
Tributyl phosphate |
||||||||||
(126-73-8) |
0.2 |
2.2 |
||||||||
Trichloroacetic acid |
||||||||||
(76-03-9) |
1 |
6.7 |
||||||||
1,2,4-Trichlorobenzene |
||||||||||
(120-82-1) |
5 |
37 | ||||||||
1,1,1-Trichloro-2,2-bis-(p-chlorophenyl)ethane |
||||||||||
(50-29-3) |
1 |
|||||||||
1,1,1-Trichloroethane |
||||||||||
(71-55-6) |
350 |
1,910 |
450 |
2,455 |
||||||
1,1,2-Trichloroethane |
||||||||||
(79-00-5) — Skin |
10 |
55 |
||||||||
Trichloroethylene |
||||||||||
(79-01-6) |
50 |
100 |
||||||||
Trichlorofluoromethane |
||||||||||
(75-69-4) |
1,000 |
5,600 | ||||||||
Trichloromethane |
||||||||||
(67-66-3) |
10 |
49 |
||||||||
Trichloromethanesulfenyl chloride |
||||||||||
(594-42-3) |
0.1 |
0.8 |
||||||||
Trichloronaphthalene |
||||||||||
(1321-65-9) — Skin |
5 |
|||||||||
Trichloronitromethane |
||||||||||
(76-06-2) |
0.1 |
0.67 |
0.3 |
2 |
||||||
(2,4,5-Trichlorophenoxy) acetic acid and esters of (as 2,4,5-T) |
||||||||||
(93-76-5) |
10 |
|||||||||
1,2,3-Trichloropropane |
||||||||||
(96-18-4) — Skin |
10 |
60 |
||||||||
1,1,2-Trichloro-1,2,2-trifluoroethane |
||||||||||
(76-13-1) |
1,000 |
7,650 |
1,250 |
9,560 |
||||||
Trichlorphon, inhalable |
||||||||||
(52-68-6) |
1 |
|||||||||
Tri-ortho-cresyl phosphate |
||||||||||
(78-30-8) — Skin |
0.1 |
|||||||||
Triethanolamine |
||||||||||
(102-71-6) |
0.5 |
3.1 |
||||||||
Triethylamine |
||||||||||
(121-44-8) |
1 |
3 |
||||||||
Triethylenediamine |
||||||||||
(280-57-9) — Skin |
1 |
4.6 |
||||||||
Triethylenetetramine |
||||||||||
(112-24-3) — Skin |
0.5 |
3 |
||||||||
1,3,5-Triglycidyl-s-triazinetrione |
||||||||||
(2451-62-9) |
0.05 |
|||||||||
3,5,5-Trimethyl-2-cyclohexen-1-one |
||||||||||
(78-59-1) |
5 |
28 | ||||||||
Trimellitic anhydride |
||||||||||
(552-30-7) |
0.04 | |||||||||
Trimethoxyvinylsilane |
||||||||||
(2768-02-7) |
10 |
60 |
||||||||
Trimethylamine |
||||||||||
(75-50-3) |
5 |
15 |
||||||||
Trimethylbenzene (sum of isomers) |
||||||||||
(25551-13-7) |
25 |
123 |
||||||||
Trimethyl phosphite |
||||||||||
(121-45-9) |
2 |
10 |
||||||||
2,4,6-Trinitrophenol |
||||||||||
(88-89-1) — Skin |
0.1 |
0.3 |
||||||||
Triphenyl amine |
||||||||||
(603-34-9) |
5 |
|||||||||
Triphenyl phosphate |
||||||||||
(115-86-6) |
3 |
|||||||||
Trixylylphosphate |
||||||||||
(25155-23-1) |
0.1 |
|||||||||
Tungsten, water-insoluble compounds of (as tungsten) |
||||||||||
(7440-33-7) |
5 |
10 |
||||||||
Tungsten, water-soluble compounds of, including tungstic acids, phosphotungstic acids and their salts (as tungsten) |
||||||||||
(7440-33-7) |
1 |
3 |
||||||||
Turpentine and selected monoterpenes |
||||||||||
(8006-64-2; 80-56-8; 127-91-3; 13466-78-9) |
20 |
|||||||||
Uranium (natural) and its compounds (as uranium) |
||||||||||
(7440-61-1) |
0.2 |
0.6 |
||||||||
V.M.& P. Naphtha1 |
||||||||||
(8030-30-6) |
1,350 |
|||||||||
n-Valeraldehyde |
||||||||||
(110-62-3) |
50 |
175 |
||||||||
Vanadium respirable dust and fume (as vanadium pentoxide) |
||||||||||
(1314-62-1) |
0.05 |
|||||||||
Vegetable oils (mists) except mists of irritant oils such as oils of castor and cashew nut |
10 |
|||||||||
Vinyl acetate |
||||||||||
(108-05-4) |
10 |
15 |
||||||||
Vinyl bromide |
||||||||||
(593-60-2) |
0.5 |
|||||||||
4-Vinyl cyclohexene |
||||||||||
(100-40-3) |
0.1 |
|||||||||
Vinyl fluoride |
||||||||||
(75-02-5) |
1 |
|||||||||
Vinylidene fluoride |
||||||||||
(75-38-7) |
500 |
|||||||||
N-Vinyl-2-pyrrolidone |
||||||||||
(88-12-0) |
0.05 |
|||||||||
Vinyltoluene (mixture of m- and p-isomers) |
||||||||||
(25013-15-4) |
50 |
241 |
100 |
482 |
||||||
Warfarin |
||||||||||
(81-81-2) |
0.1 |
|||||||||
Welding fume, not otherwise specified |
||||||||||
Aluminum-containing (as Aluminum) |
||||||||||
(7429-90-5) |
5 |
|||||||||
Iron-containing (as iron) |
||||||||||
(7439-89-6) |
5 |
|||||||||
Other, not otherwise classified (total weight, oil free) |
5 |
|||||||||
Wheat flour dust (total dust) |
3 |
|||||||||
Wood dust |
||||||||||
- certain hardwoods as beech and oak |
1 |
|||||||||
- softwood |
5 |
10 |
||||||||
m-Xylene-alpha, alpha’-diamine |
||||||||||
(1477-55-0) — Skin |
0.1 | |||||||||
Yttrium, metal and compounds (as yttrium) |
||||||||||
(7440-65-5) |
1 |
|||||||||
Zinc chloride fume |
||||||||||
(7646-85-7) |
1 |
2 |
||||||||
Zinc chromates, |
||||||||||
(13530-65-9;11103-86-9;37300-23-5) as Cr |
0.01 |
|||||||||
Zinc oxide, respirable |
||||||||||
(1314-13-2) |
2 |
10 |
||||||||
Zirconium compounds (as zirconium) |
||||||||||
(7440-67-7) |
5 |
10 |
||||||||
* Special exceptions may apply to this substance; see section 9 of the Regulation.
Note: On December 31, 2007, Part 4 of the Schedule is amended by striking out “*Special exceptions may apply to this substance; see section 9 of the Regulation” at the end of the Table. See: O. Reg. 607/05, ss. 5 (5), 8 (3).
Footnotes
(A) Provided that the total dust contains less than 0.7% vanadium.
(B) Provided that the respirable dust concentration does not exceed 2 mg/m3.
(C) For assessing the visibility in a work environment where 1,2-propylene glycol aerosol is present.
(D) The value is for particulate matter containing no asbestos and less than 1% crystalline silica.
(E) A secondary limit of 5 mg/m3 (total dust) is recommended to deal with dusty operations where fibre counts are usually difficult to determine. Where both types of measurements are made simultaneously, the more restrictive limit should be used to assess the exposures.
(F) As measured by the vertical elutraitor, cotton-dust sampler.
(G) Application of limit restricted to conditions in which there are negligible aerosol exposures.
(H) Respirable fibres: length greater than 5 microns; aspect ratio greater than or equal to 3:1 as determined by the membrane filter method at 400-450 times magnification (4 mm objective), using phase-contrast illumination.
1 As sum of components assayed by chromatographic procedure with reference to the bulk sample.
O. Reg. 16/05, s. 1 (1); O. Reg. 77/05, s. 1; O. Reg. 177/05, s. 1; O. Reg. 607/05, s. 5 (1, 2, 6).
PART 5 Revoked: O. Reg. 388/00, s. 7.
PART 6 Revoked: O. Reg. 388/00, s. 7.
PART 7 Revoked: O. Reg. 388/00, s. 7.
PART 8 Revoked: O. Reg. 388/00, s. 7.
PART 9
EXPOSURE VALUES FOR SIMPLE ASPHYXIANTS
The agents listed below are examples of simple asphyxiants which have not been assigned any definite exposure values. These agents cause asphyxiation by diluting the atmospheric oxygen level below that required to maintain normal respiratory function. If any of the listed gases and vapours is present in the air, the minimal oxygen content should not be less than 18 per cent by volume at any time. A number of the simple asphyxiants can form explosive mixtures in air; therefore, the explosive hazard should be considered when limiting the airborne concentration of these asphyxiants.
Agent |
(CAS Reg. No.) |
Acetylene |
(74-86-2) |
Argon |
(7440-37-1) |
Helium |
(7440-59-7) |
Hydrogen |
(1333-74-0) |
Neon |
(7440-01-9) |
Nitrogen |
(7727-37-9) |
Propylene |
(115-07-1) |
R.R.O. 1990, Reg. 833, Sched., Part 9; O. Reg. 16/05, s. 1 (4); O. Reg. 607/05, s. 6.
PART 10
KNOWN TOXIC AGENTS FOR WHICH EXPOSURE VALUES HAVE NOT BEEN ESTABLISHED, AND TO WHICH ANY EXPOSURE SHOULD BE AVOIDED
Agent |
(CAS Reg. No.) |
Benzidine — Skin |
(92-87-5) |
Benzo(a)pyrene |
(50-32-8) |
(1,1´-Biphenyl)-4-amine — Skin |
(92-67-1) |
Chloromethyl methyl ether |
(107-30-2) |
Chrysene |
(218-01-9) |
1,2-Dibromoethane — Skin |
(106-93-4) |
3,3´Dichlorobenzidine — Skin |
(91-94-1) |
3,3´-Dimethyl-(1,1´-biphenyl)-4,4´diamine — Skin |
(119-93-7) |
Dimethylcarbamoyl chloride |
(79-44-7) |
Hexamethylphosphoric triamide — Skin |
(680-31-9) |
beta-Naphthylamine |
(91-59-8) |
4-Nitrobiphenyl |
(92-93-3) |
N-Nitrosamines — Skin (e.g. NNitrosodimethylamine) |
|
1,2-Oxathiolane 2,2-dioxide |
(1120-71-4) |
N-Phenyl-beta-naphthylamine |
(135-88-6) |
Rosin core solder pyrolysis products (as formaldehyde) |
R.R.O. 1990, Reg. 833, Sched., Part 10; O. Reg. 100/04, s. 6; O. Reg. 607/05, s. 7.
PART 11
EXPOSURE VALUES* FOR ACRYLONITRILE, BENZENE AND MERCURY
Agent |
TWAEV |
STEV |
CEV | |||
ppm |
mg/m3 |
ppm |
mg/m3 |
ppm |
mg/m3 | |
Acrylonitrile |
2 |
4.3 |
||||
Benzene |
1 |
5.0 |
||||
Note: On December 31, 2005, Part 11 of the Schedule is amended by striking out the following item: | ||||||
Benzene |
1 |
5.0 |
||||
See: O. Reg. 100/04, s. 7 (2), 8 (3). | ||||||
Note: On December 31, 2005, Part 11 of the Schedule is amended by adding the following item: | ||||||
Benzene |
0.5 |
2.5 |
||||
See: O. Reg. 100/04, s. 7 (3), 8 (3). | ||||||
Mercury |
||||||
- All forms of except alkyl (as mercury) |
0.025 |
|||||
- Alkyl compounds of (as mercury) |
0.01 |
0.03 |
||||
* The values listed in this part apply to workplaces to which the designated substance regulation does not apply.
O. Reg. 100/04, s. 7 (1); O. Reg. 16/05, s. 1 (5).
R.R.O. 1990, Reg. 833, Sched.; O. Reg. 597/94, ss. 1, 2; O. Reg. 388/00, ss. 1-9; O. Reg. 100/04, ss. 2-7; O. Reg. 16/05, s. 1 (1), (4, 5); O. Reg. 607/05, ss. 4, 5 (1, 2, 6), 6, 7.
